Skip to content

Abstract 14304: Aortic Stenosis Identifies a High-Risk Phenotype in Non-Amyloid Restrictive Cardiomyopathy: A 10-Year Global Cohort Study

Nov 2026 · Circulation · 0 citations

Abstract

Background: Restrictive cardiomyopathy (RCM) is associated with substantial morbidity and mortality due to progressive diastolic dysfunction and heart failure. The prognostic implications of concomitant non-rheumatic aortic stenosis (AS) in patients with RCM remain poorly characterized. Understanding the long-term interaction between these conditions may help identify patients at increased risk for adverse cardiovascular outcomes. Methods: We performed a retrospective cohort study using the TriNetX Research Network. Adult patients diagnosed with restrictive cardiomyopathy (ICD-10-CM I42.5) between 2006 and 2024 were identified. Patients with cardiomyopathy due to amyloidosis (E85, I43) were excluded. The exposure cohort included patients with concomitant non-rheumatic aortic stenosis (ICD-10-CM I35.0, I35.2), while the control cohort consisted of patients with RCM without aortic stenosis.After 1:1 propensity score matching for demographics, cardiovascular risk factors, comorbidities, laboratory values, and baseline clinical characteristics with standardized mean differences <0.10) in all covariates. Outcomes were assessed at 1 year and long term 10 years. Hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated. Results: Following propensity matching, patients with RCM and concomitant AS demonstrated significantly higher risks of several clinically important cardiovascular outcomes. At 1 year, AS was associated with increased all-cause mortality (HR 1.08, 95% CI 1.03-1.13; p=0.002), atrial fibrillation/flutter (HR 1.34, 95% CI 1.25-1.44; p<0.001), acute MI (HR 1.13, 95% CI 1.03-1.23; p=0.008), and cardiogenic shock (HR 1.60, 95% CI 1.41-1.81; p<0.001). No significant differences were observed in heart failure, stroke, or MACCE.At 10 years, mortality was no longer significantly different between groups (HR 1.02, 95% CI 0.99-1.05; p=0.118). However, patients with AS continued to experience higher risks of heart failure (HR 1.11, 95% CI 1.06-1.16; p<0.001), atrial fibrillation/flutter (HR 1.25, 95% CI 1.19-1.30; p<0.001), stroke (HR 1.10, 95% CI 1.04-1.17; p=0.001), and cardiogenic shock (HR 1.40, 95% CI 1.30-1.51; p<0.001). Long-term risks of acute MI, MACCE, and mortality remained comparable between cohorts. Conclusions: Among patients with restrictive cardiomyopathy, concomitant non-rheumatic aortic stenosis identifies a high-risk phenotype associated with substantially increased risks of atrial arrhythmias, cardiogenic shock, heart failure progression, and stroke. Although long-term mortality and MACCE were not significantly increased, the persistent excess burden of adverse cardiovascular events suggests that AS contributes importantly to disease progression in RCM. Enhanced surveillance and earlier consideration of valve-directed and heart failure therapies may be warranted in this vulnerable population.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.